{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T11:57:05Z","timestamp":1769860625251,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2407-14-902","type":"journal-article","created":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T19:03:44Z","timestamp":1417547024000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Recurrent CYP2C19 deletion allele is associated with triple-negative breast cancer"],"prefix":"10.1186","volume":"14","author":[{"given":"Anna","family":"Tervasm\u00e4ki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Winqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arja","family":"Jukkola-Vuorinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katri","family":"Pylk\u00e4s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,2]]},"reference":[{"issue":"2","key":"5069_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nrg3373","volume":"14","author":"J Weischenfeldt","year":"2013","unstructured":"Weischenfeldt J, Symmons O, Spitz F, Korbel JO: Phenotypic impact of genomic structural variation: insights from and for human disease. Nat Rev Genet. 2013, 14 (2): 125-138. 10.1038\/nrg3373.","journal-title":"Nat Rev Genet"},{"issue":"7145","key":"5069_CR2","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature05911","volume":"447","author":"Wellcome Trust Case Control Consortium","year":"2007","unstructured":"Wellcome Trust Case Control Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007, 447 (7145): 661-678. 10.1038\/nature05911.","journal-title":"Nature"},{"issue":"1","key":"5069_CR3","doi-asserted-by":"publisher","first-page":"R24","DOI":"10.1186\/bcr3109","volume":"14","author":"AC Krepischi","year":"2012","unstructured":"Krepischi AC, Achatz MI, Santos EM, Costa SS, Lisboa BC, Brentani H, Santos TM, Goncalves A, Nobrega AF, Pearson PL, Vianna-Morgante AM, Carraro DM, Brentani RR, Rosenberg C: Germline DNA copy number variation in familial and early-onset breast cancer. Breast Cancer Res. 2012, 14 (1): R24-10.1186\/bcr3109.","journal-title":"Breast Cancer Res"},{"issue":"6","key":"5069_CR4","doi-asserted-by":"publisher","first-page":"e1002734","DOI":"10.1371\/journal.pgen.1002734","volume":"8","author":"K Pylk\u00e4s","year":"2012","unstructured":"Pylk\u00e4s K, Vuorela M, Otsukka M, Kallioniemi A, Jukkola-Vuorinen A, Winqvist R: Rare copy number variants observed in hereditary breast cancer cases disrupt genes in estrogen signaling and TP53 tumor suppression network. PLoS Genet. 2012, 8 (6): e1002734-10.1371\/journal.pgen.1002734.","journal-title":"PLoS Genet"},{"issue":"2","key":"5069_CR5","first-page":"148","volume":"22","author":"ZN Cheng","year":"2001","unstructured":"Cheng ZN, Shu Y, Liu ZQ, Wang LS, Ou-Yang DS, Zhou HH: Role of cytochrome P450 in estradiol metabolism in vitro. Acta Pharmacol Sin. 2001, 22 (2): 148-154.","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"5069_CR6","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1158\/1055-9965.EPI-05-0801","volume":"15","author":"AE Cribb","year":"2006","unstructured":"Cribb AE, Knight MJ, Dryer D, Guernsey J, Hender K, Tesch M, Saleh TM: Role of polymorphic human cytochrome P450 enzymes in estrone oxidation. Cancer Epidemiol Biomarkers Prev. 2006, 15 (3): 551-558. 10.1158\/1055-9965.EPI-05-0801.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"5069_CR7","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1124\/dmd.30.8.869","volume":"30","author":"HK Crewe","year":"2002","unstructured":"Crewe HK, Notley LM, Wunsch RM, Lennard MS, Gillam EM: Metabolism of tamoxifen by recombinant human cytochrome P450 enzymes: formation of the 4-hydroxy, 4'-hydroxy and N-desmethyl metabolites and isomerization of trans-4-hydroxytamoxifen. Drug Metab Dispos. 2002, 30 (8): 869-874. 10.1124\/dmd.30.8.869.","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"5069_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1006\/geno.1998.5281","volume":"49","author":"G Kremmidiotis","year":"1998","unstructured":"Kremmidiotis G, Baker E, Crawford J, Eyre HJ, Nahmias J, Callen DF: Localization of human cadherin genes to chromosome regions exhibiting cancer-related loss of heterozygosity. Genomics. 1998, 49 (3): 467-471. 10.1006\/geno.1998.5281.","journal-title":"Genomics"},{"issue":"6805","key":"5069_CR9","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/35037710","volume":"407","author":"MO Hengartner","year":"2000","unstructured":"Hengartner MO: The biochemistry of apoptosis. Nature. 2000, 407 (6805): 770-776. 10.1038\/35037710.","journal-title":"Nature"},{"issue":"6","key":"5069_CR10","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1158\/1078-0432.CCR-03-0236","volume":"10","author":"H Dote","year":"2004","unstructured":"Dote H, Toyooka S, Tsukuda K, Yano M, Ouchida M, Doihara H, Suzuki M, Chen H, Hsieh JT, Gazdar AF, Shimizu N: Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in breast cancer. Clin Cancer Res. 2004, 10 (6): 2082-2089. 10.1158\/1078-0432.CCR-03-0236.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"5069_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng.2007.53","volume":"40","author":"MR Stratton","year":"2008","unstructured":"Stratton MR, Rahman N: The emerging landscape of breast cancer susceptibility. Nat Genet. 2008, 40 (1): 17-22. 10.1038\/ng.2007.53.","journal-title":"Nat Genet"},{"issue":"1","key":"5069_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/jid.2008.201","volume":"129","author":"P Singh","year":"2009","unstructured":"Singh P, Chen C, Pal-Ghosh S, Stepp MA, Sheppard D, Van De Water L: Loss of integrin alpha9beta1 results in defects in proliferation, causing poor re-epithelialization during cutaneous wound healing. J Invest Dermatol. 2009, 129 (1): 217-228. 10.1038\/jid.2008.201.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"5069_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1182\/blood-2009-01-197988","volume":"114","author":"J Grassinger","year":"2009","unstructured":"Grassinger J, Haylock DN, Storan MJ, Haines GO, Williams B, Whitty GA, Vinson AR, Be CL, Li S, Sorensen ES, Tam PP, Denhardt DT, Sheppard D, Choong PF, Nilsson SK: Thrombin-cleaved osteopontin regulates hemopoietic stem and progenitor cell functions through interactions with alpha9beta1 and alpha4beta1 integrins. Blood. 2009, 114 (1): 49-59. 10.1182\/blood-2009-01-197988.","journal-title":"Blood"},{"issue":"10","key":"5069_CR14","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1091\/mbc.12.10.3214","volume":"12","author":"BA Young","year":"2001","unstructured":"Young BA, Taooka Y, Liu S, Askins KJ, Yokosaki Y, Thomas SM, Sheppard D: The cytoplasmic domain of the integrin alpha9 subunit requires the adaptor protein paxillin to inhibit cell spreading but promotes cell migration in a paxillin-independent manner. Mol Biol Cell. 2001, 12 (10): 3214-3225. 10.1091\/mbc.12.10.3214.","journal-title":"Mol Biol Cell"},{"issue":"2","key":"5069_CR15","first-page":"404","volume":"63","author":"A Protopopov","year":"2003","unstructured":"Protopopov A, Kashuba V, Zabarovska VI, Muravenko OV, Lerman MI, Klein G, Zabarovsky ER: An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies. Cancer Res. 2003, 63 (2): 404-412.","journal-title":"Cancer Res"},{"issue":"21","key":"5069_CR16","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","volume":"295","author":"LA Carey","year":"2006","unstructured":"Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC: Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006, 295 (21): 2492-2502. 10.1001\/jama.295.21.2492.","journal-title":"JAMA"},{"issue":"24","key":"5069_CR17","doi-asserted-by":"publisher","first-page":"8010","DOI":"10.1158\/1078-0432.CCR-08-1208","volume":"14","author":"BP Schneider","year":"2008","unstructured":"Schneider BP, Winer EP, Foulkes WD, Garber J, Perou CM, Richardson A, Sledge GW, Carey LA: Triple-negative breast cancer: risk factors to potential targets. Clin Cancer Res. 2008, 14 (24): 8010-8018. 10.1158\/1078-0432.CCR-08-1208.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"5069_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000028398","volume":"61","author":"PJ Wedlund","year":"2000","unstructured":"Wedlund PJ: The CYP2C19 enzyme polymorphism. Pharmacology. 2000, 61 (3): 174-183. 10.1159\/000028398.","journal-title":"Pharmacology"},{"issue":"4","key":"5069_CR19","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0026-895X(25)09788-3","volume":"46","author":"SM De Morais","year":"1994","unstructured":"De Morais SM, Wilkinson GR, Blaisdell J, Meyer UA, Nakamura K, Goldstein JA: Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese. Mol Pharmacol. 1994, 46 (4): 594-598.","journal-title":"Mol Pharmacol"},{"issue":"7","key":"5069_CR20","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1097\/00008571-200010000-00004","volume":"10","author":"PL Roddam","year":"2000","unstructured":"Roddam PL, Rollinson S, Kane E, Roman E, Moorman A, Cartwright R, Morgan GJ: Poor metabolizers at the cytochrome P450 2D6 and 2C19 loci are at increased risk of developing adult acute leukaemia. Pharmacogenetics. 2000, 10 (7): 605-615. 10.1097\/00008571-200010000-00004.","journal-title":"Pharmacogenetics"},{"issue":"1","key":"5069_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.clpt.2005.10.002","volume":"79","author":"SC Sim","year":"2006","unstructured":"Sim SC, Risinger C, Dahl ML, Aklillu E, Christensen M, Bertilsson L, Ingelman-Sundberg M: A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants. Clin Pharmacol Ther. 2006, 79 (1): 103-113. 10.1016\/j.clpt.2005.10.002.","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"5069_CR22","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/j.1365-2125.2008.03104.x","volume":"65","author":"RM Baldwin","year":"2008","unstructured":"Baldwin RM, Ohlsson S, Pedersen RS, Mwinyi J, Ingelman-Sundberg M, Eliasson E, Bertilsson L: Increased omeprazole metabolism in carriers of the CYP2C19*17 allele; a pharmacokinetic study in healthy volunteers. Br J Clin Pharmacol. 2008, 65 (5): 767-774. 10.1111\/j.1365-2125.2008.03104.x.","journal-title":"Br J Clin Pharmacol"},{"key":"5069_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0076-6879(96)72025-6","volume":"272","author":"JA Goldstein","year":"1996","unstructured":"Goldstein JA, Blaisdell J: Genetic tests which identify the principal defects in CYP2C19 responsible for the polymorphism in mephenytoin metabolism. Methods Enzymol. 1996, 272: 210-218.","journal-title":"Methods Enzymol"},{"issue":"1","key":"5069_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1479-7364-3-1-17","volume":"3","author":"HL Hsu","year":"2008","unstructured":"Hsu HL, Woad KJ, Woodfield DG, Helsby NA: A high incidence of polymorphic CYP2C19 variants in archival blood samples from Papua New Guinea. Hum Genomics. 2008, 3 (1): 17-23. 10.1186\/1479-7364-3-1-17.","journal-title":"Hum Genomics"},{"issue":"10","key":"5069_CR25","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/jnci\/dji132","volume":"97","author":"R Kaaks","year":"2005","unstructured":"Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, de Mesquita HB B, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quiros JR, Roddam A, et al: Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2005, 97 (10): 755-765. 10.1093\/jnci\/dji132.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"5069_CR26","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1371\/journal.pgen.0010049","volume":"1","author":"JR Lupski","year":"2005","unstructured":"Lupski JR, Stankiewicz P: Genomic disorders: molecular mechanisms for rearrangements and conveyed phenotypes. PLoS Genet. 2005, 1 (6): e49-10.1371\/journal.pgen.0010049.","journal-title":"PLoS Genet"},{"issue":"2","key":"5069_CR27","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10549-008-0076-4","volume":"115","author":"C Justenhoven","year":"2009","unstructured":"Justenhoven C, Hamann U, Pierl CB, Baisch C, Harth V, Rabstein S, Spickenheuer A, Pesch B, Bruning T, Winter S, Ko YD, Brauch H: CYP2C19*17 is associated with decreased breast cancer risk. Breast Cancer Res Treat. 2009, 115 (2): 391-396. 10.1007\/s10549-008-0076-4.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"5069_CR28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10549-012-2339-3","volume":"137","author":"M Pierobon","year":"2013","unstructured":"Pierobon M, Frankenfeld CL: Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis. Breast Cancer Res Treat. 2013, 137 (1): 307-314. 10.1007\/s10549-012-2339-3.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"5069_CR29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.tem.2011.10.003","volume":"23","author":"SE Bulun","year":"2012","unstructured":"Bulun SE, Chen D, Moy I, Brooks DC, Zhao H: Aromatase, breast cancer and obesity: a complex interaction. Trends Endocrinol Metab. 2012, 23 (2): 83-89. 10.1016\/j.tem.2011.10.003.","journal-title":"Trends Endocrinol Metab"},{"issue":"11","key":"5069_CR30","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1002\/ijc.23192","volume":"121","author":"A Federico","year":"2007","unstructured":"Federico A, Morgillo F, Tuccillo C, Ciardiello F, Loguercio C: Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer. 2007, 121 (11): 2381-2386. 10.1002\/ijc.23192.","journal-title":"Int J Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-902.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-902\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-902","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-902.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T22:36:26Z","timestamp":1747175786000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["5069"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-902","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"11 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"902"}}